Global Single Nucleotide Polymorphism (SNP) Genotyping Market Trends 2025–2029: Regional Outlook and Sizing Analysis

Global Single Nucleotide Polymorphism (SNP) Genotyping Market

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Single Nucleotide Polymorphism (SNP) Genotyping Market Be Worth By 2029?

The market size for single nucleotide polymorphism (snp) genotyping has been swiftly expanding over the recent years. The expansion is projected to rise from $10.3 billion in 2024 to $12.34 billion in 2025, with a compound annual growth rate (CAGR) of 19.8%. The surge seen in the historic period can be credited to the escalating research in genomics, increasing instances of genetic disorders, advancements in personalized medicine, the blossoming pharmaceutical industry, and the growing demand for molecular diagnostics.

The market size of single nucleotide polymorphism (snp) genotyping is predicted to experience a significant expansion in the coming years. It is projected to surge to $24.89 billion in 2029, with a compound annual growth rate (CAGR) of 19.2%. The anticipated growth during the forecast period could be due to the escalating use in disease research, an increased requirement for precision medicine, growing biobanking efforts, an upsurge in genetic testing, and its widening adoption in agriculture for enhancing crops. Noteworthy trends during the forecast period comprise the amplified use of next-generation sequencing (NGS), a burgeoning demand for SNP genotyping in pharmacogenomics, the rise of direct-to-consumer genetic testing, an emphasis on automation, and high-throughput genotyping platforms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12569&type=smp

Which Key Factors Are Fueling Growth In The Single Nucleotide Polymorphism (SNP) Genotyping Market?

The escalating prevalence of enduring ailments is anticipated to fuel the expansion of the single nucleotide polymorphism (SNP) genotyping market. Persistent diseases, which last for a year or more and require ongoing medical attention or interfere with daily activities, enhance the necessity for SNP genotyping. This technique is essential for determining genetic proclivity and promoting individualized treatment due to the rise in chronic conditions. For instance, data from the Australian Institute of Health and Welfare in June 2024 showed an increase in death rates related to chronic diseases, from 459 deaths per 100,000 individuals in 2021 to 490 deaths per 100,000 individuals in 2022. Consequently, the escalating prevalence of persistent conditions augments the growth of the single nucleotide polymorphism (SNP) genotyping systems market.

Which Segmentation Factors Are Critical In The Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis?

The single nucleotide polymorphism (snp) genotypingmarket covered in this report is segmented –

1) By Product: Consumables; Instruments; Services

2) By Technology: TaqMan SNP Genotyping; Mass Array SNP Genotyping; SNP Gene Chip Arrays; Other Technologies

3) By Application: Animal Genetics; Plant Improvement; Diagnostic Research; Pharmaceuticals And Pharmacogenomics; Agricultural Biotechnology; Other Applications

Subsegments:

1) By Consumables: Reagents And Kits; DNA Probes; Microarrays

2) By Instruments: SNP Genotyping Platforms; Sequencers; PCR Machines

3) By Services: SNP Genotyping Services; Data Analysis Services; Consultation Services

What Are The Dominant Trends Currently Seen In The Single Nucleotide Polymorphism (SNP) Genotyping Market?

The growing trend of technological innovations is gaining traction in the single nucleotide polymorphism (SNP) genotyping market. To maintain their market standing, prominent businesses in the single nucleotide polymorphism (SNP) genotyping sector are launching high-tech solutions. For example, in May 2022, Neogen Corporation, an American company that offers agricultural, animal protein, food and beverage industry solutions, and Gencove, an American sequencing solutions provider, introduced InfiniSEEK. This tool is the pioneer comprehensive genome and genotyping solution for cattle breeders. The comprehensive validation of InfiniSEEK shows that low-pass genome-wide sequencing aligns more than 99% with deep whole-genome sequencing and can deliver even greater clinical-grade precision in certain areas of interest.

Which Players Are Shaping The Competitive Landscape Of The Single Nucleotide Polymorphism (SNP) Genotyping Market?

Major companies operating in the single nucleotide polymorphism (SNP) genotyping market include Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Single Nucleotide Polymorphism (SNP) Genotyping Market?

North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (SNP) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12569&type=smp

Browse Through More Reports Similar to the Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2025, By The Business Research Company

Genotyping Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Tissue Microarray Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Molecular Breeding Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-breeding-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model